KO
Kim Ohaegbulam
Physician · Kaiser Permanente Mid-Atlantic States
Credentials: · · · · ·
History
2025–Present
- 2020–2024
Radiation Oncology
- 2019–2020
Preliminary or Transitional Year
2015–2019
Research
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Review · Trends in Molecular Medicine · 2015 · First of 5 authors · 683 citations
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Clinical Cancer Research · 2016 · Co-first of 3 authors · 474 citations
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Proceedings of the National Academy of Sciences of the United States of America · 2013 · 172 citations
3 papers
- CP
2 papers · 1 as a resident
2 papers
2 papers
- MJ
2 papers
- TM
2 papers
1 paper
1 paper · 1 as a resident
